Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > Endocrinology > Endocrinology Hyperlipidemia

Hyperlipidemia

Hyperlipidemia is a set of metabolic disorders that can be genetic or acquired that are characterized by excess lipids in the blood which can include cholesterol and/or triglycerides. This excess causes increased fatty acid deposition which leads to blockages in the arteries. 
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Hyperlipidemia is a set of metabolic disorders that can be genetic or acquired that are characterized by excess lipids in the blood which can include cholesterol and/or triglycerides. This excess causes increased fatty acid deposition which leads to blockages in the arteries. This, in turn can lead to the development of atherosclerotic plaques throughout the body and subsequent vascular disease. Genetic hyperlipidemia is mostly inherited in an autosomal dominant manner but can also be inherited in an autosomal recessive pattern. Hyperlipidemia is a general term used to identify a disease associated with excess lipids and/or fats in the body and hypercholesterolemia is one of the most common forms of hyperlipidemia.  

  • The Igenomix Hyperlipidemia Precision Panel can be used to make a directed and accurate differential diagnosis of excess lipids ultimately leading to a better management and prognosis of the disease and its outcomes. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

Indication

The Igenomix Hyperlipidemia Precision Panel is indicated for those patients with clinical suspicion of inherited hyperlipidemia presenting with the following manifestations: 

  • High cholesterol  
  • High blood pressure  
  • Symptoms of peripheral artery disease: leg discomfort, leg pain or cramps when walking, pain in the ball of the foot, foot ulcers. 
  • Symptoms of stroke: sudden severe headache, weakness, numbness, loss of movement in one arm, partial vision loss, inability to speak clearly.  
  • Symptoms of heart attack: chest pain, shortness of breath, sweating. 

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team for early pharmacologic therapy, dietary modifications, and primary prevention to reduce comorbidities associated with hyperlipidemia. 
  • Risk assessment of asymptomatic family members according to the mode of inheritance. 

Genes & Diseases

Methodology

References

See scientific referrals

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, European Heart Journal, Volume 41, Issue 44, 21 November 2020, Page 4255, https://doi.org/10.1093/eurheartj/ehz826 

Hill MF, Bordoni B. Hyperlipidemia. [Updated 2020 Sep 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559182/ 

Bello-Chavolla, O. Y., Kuri-García, A., Ríos-Ríos, M., Vargas-Vázquez, A., Cortés-Arroyo, J. E., Tapia-González, G., Cruz-Bautista, I., & Aguilar-Salinas, C. A. (2018). FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 70(5), 224–236. https://doi.org/10.24875/RIC.18002575 

Taghizadeh, E., Esfehani, R. J., Sahebkar, A., Parizadeh, S. M., Rostami, D., Mirinezhad, M., Poursheikhani, A., Mobarhan, M. G., & Pasdar, A. (2019). Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies. IUBMB life, 71(9), 1221–1229. https://doi.org/10.1002/iub.2073 

descargar

Detail description

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information